SEC Filing Analysis: COGNEX CORP

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director at Cognex has filed a notice of a proposed sale of stock valued at approximately $332k, a transaction of low financial significance executed under a pre-arranged 10b5-1 trading plan.
• Market Impact: The transaction is negligible relative to the company's market capitalization and daily trading volume, and is unlikely to have any impact on the stock price.

Company Information

Field	Value
Company	COGNEX CORP
Ticker Symbol	Not provided in filing (CGNX)
CIK	0000851205
Industry	Industrial Instruments for Measurement, Display, and Control

Insider Information

Field	Value
Name	Willett Robert
CIK	0001438093
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	144 (Notice of Proposed Sale)
Transaction Date	2025-10-21
Transaction Code	Not Applicable
Security Type	Common Stock
Shares Involved	6,704
Price Per Share	~$49.51 (calculated)
Total Value	$331,889.61
Shares Owned After	Not Disclosed
Ownership Type	Not Disclosed

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$331,889.61
% of Market Cap	0.0042%
Shares Transacted	6,704
% of Shares Outstanding	0.0040%
Post-Transaction Ownership	Not Disclosed
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $7.94 billion, this $332k transaction is financially immaterial.
• Ownership Concentration: Ownership data after the transaction is not available in a Form 144, but the small size of the sale suggests it is unlikely to significantly alter the director's stake.
• Dilution Impact: Not applicable, as this is a sale of existing shares, not an issuance.
• Transaction Significance: The sale represents a tiny fraction of both the company's market value and its total shares outstanding. Based on quantitative thresholds, the significance is very low.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sale is de minimis and was conducted under a 10b5-1 plan. The market typically discounts such sales as they are pre-scheduled and not necessarily indicative of an insider's current view on the company's prospects.

Volume & Sentiment

• Expected Volume Impact: None. The number of shares is too small to affect trading volume patterns.
• Sentiment Indicator: Neutral. This is a routine, non-indicative transaction.

Investment Insights

Positive Market Indicators

• No positive indicators can be drawn from this filing.

Risk Factors

• No new risk factors are highlighted by this routine filing.

Key Takeaways

1. Low Materiality: The transaction value is less than 0.005% of Cognex's market cap, making it financially insignificant.
2. 10b5-1 Plan: The sale was made pursuant to a trading plan adopted on May 6, 2025. This removes the implication that the sale is based on recent non-public information.
3. Routine Transaction: This filing represents a routine diversification or liquidity event for the insider and does not signal a change in their confidence in the company.

Additional Context

Transaction Notes

• Special Circumstances: The filing notes a 10b5-1 plan adoption date, which provides important context that this was a pre-planned sale.
• Nature of Transaction: The shares were acquired via an option grant from 2017, and this sale is the realization of value from that grant.